Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation

Biochemical Pharmacology

Volumn 60, Issue 7, 2000, Pages 979-988

  McNaught, Kevin St P ^a   Jenner, Peter ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

1 methyl 4 phenylpyridinium; Astrocytes; Glutamate; Hydrogen peroxide; Nitric oxide; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; BUTHIONINE SULFOXIMINE; GLUTAMIC ACID; GLUTATHIONE; HYDROGEN PEROXIDE; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FOREBRAIN; NERVE CELL CULTURE; NERVE CELL NECROSIS; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; ASTROCYTES; ELECTRON TRANSPORT COMPLEX I; GLUTAMIC ACID; GLUTATHIONE; HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDES; NADH, NADPH OXIDOREDUCTASES; NITRIC OXIDE; RATS; RATS, WISTAR;

EID: 0034308136     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00415-9     Document Type: Article

References (50)

1. Forno S. Pathology of Parkinson's disease. Marsden C.D., Fahn S. Movement Disorders, Neurology 2. 1981;21-40 Butterworth Scientific, London.
2. Banati R.B., Daniel S.E., Blunt S.B. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov Disord. 13:1998;221-227.
3. Jenner P., Olanow W.C. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology. 47:(Suppl 3):1996;S161-S170.
4. Sian J., Dexter D.T., Lees A.J., Daniel S., Agid Y., Javoy-Agid F., Jenner P., Marsden C.D. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol. 36:1994;348-355.
5. Dexter D.T., Carayon A., Javoy-Agid F., Agid Y., Wells F.R., Daniel S.E., Jenner P., Marsden C.D. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain. 114:1991;1953-1975.
6. Saggu H., Cooksey J., Dexter D., Wells F.R., Lees A., Jenner P., Marsden C.D. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem. 53:1989;692-697.
7. Dexter D.T., Holley A.E., Flitter W.D., Slater T.F., Wells R.F., Daniel S.E., Lees A.J., Jenner P., Marsden C.D. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra An HPLC and ESR study . Mov Disord. 9:1994;92-97.
8. Alam Z.I., Daniel S.E., Lees A.J., Marsden C.D., Jenner P., Halliwell B. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J Neurochem. 69:1997;1326-1329.
9. Sanchez-Ramos J.R., Overvik E., Ames B.N. A marker of oxyradical-mediated DNA damage (8-hydroxy-2′-deoxyguanosine) is increased in nigro-striatum in Parkinson's disease brain. Neurodegeneration. 3:1994;197-204.
10. 1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem. 55:1990;2142-2145.
11. Mizuno Y., Matuda S., Yoshino H., Mori H., Hattori N., Ikebe S. An immunohistochemical study on α-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann Neurol. 35:1994;204-210.
12. Eve D.J., Nisbet A.P., Kingsbury A.E., Hewson E.L., Daniel S.E., Lees A.J., Marsden C.D., Foster O.J. Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease. Brain Res Mol Brain Res. 63:1998;62-71.
13. Beal M.F., Brouillet E., Jenkins B., Henshaw R., Rosen B., Hyman B.T. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J Neurochem. 61:1993;1147-1150.
14. Ikonomidou C., Turski L. Neurodegenerative disorders Clues from glutamate and energy metabolism . Crit Rev Neurobiol. 10:1996;239-263.
15. McNaught K. StP, Brown G.C. Nitric oxide causes glutamate release from brain synaptosomes. J Neurochem. 70:1998;1541-1546.
16. Sagara J., Makino N., Bannai S. Glutathione efflux from cultured astrocytes. J Neurochem. 66:1996;1876-1881.
17. Morris C.M., Edwardson J.A. Iron immunohistochemistry of the substantia nigra in Parkinson's disease. Neurodegeneration. 3:1994;277-282.
18. Savolainen H. Superoxide dismutase and glutathione peroxidase activities in rat brain. Res Commun Chem Pathol Pharmacol. 21:1978;173-176.
19. Stewart V.C., Land J.M., Clark J.B., Heales S.J.R. Comparison of mitochondrial respiratory-chain enzyme activities in rodent astrocytes and neurones and a human astrocytoma cell line. Neurosci Lett. 247:1998;201-203.
20. O'Malley E.K., Black I.B., Dreyfus C.F. Local support cells promote survival of substantia nigra dopaminergic neurons in culture. Exp Neurol. 11:1991;240-248.
21. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 38:1988;1285-1291.
22. Mogi M., Harada M., Kondo T., Riederer P., Inagaki H., Minami M., Nagatsu T. Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients. Neurosci Lett. 180:1994;147-150.
23. Boka C., Anglade P., Wallach D., Javoy-Agid F., Hirsch E.C. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett. 172:1994;151-154.
24. Bolaños J.P., Peuchen S., Heales S.J., Land J.M., Clark J.B. Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J Neurochem. 63:1994;910-916.
25. Bolaños J.P., Heales S.J., Peuchen S., Barker J.E., Land J.M., Clark J.B. Nitric oxide-mediated mitochondrial damage A potential neuroprotective role for glutathione . Free Radic Biol Med. 21:1996;995-1001.
26. Chao C.C., Hu S., Peterson P.K. Glia The not so innocent bystanders . J Neurovirol. 2:1996;234-239.
27. Chao C.C., Hu S., Sheng W.S., Bu D., Bukrinsky M.I., Peterson P.K. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia. 16:1996;276-284.
28. Dawson V.L., Brahmbhatt H.P., Mong J.A., Dawson T.M. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacology. 33:1994;1425-1430.
29. Marriott D.R., Hirst W.D., Ljungberg M.C. Astrocytes. Cohen J., Wilkin G.P. Neural Cell Culture-A Practical Approach. 1995;85-96 IRL Press, Oxford.
30. Dringen R., Kranich O., Hamprecht B. The γ-glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture. Neurochem Res. 22:1997;727-733.
31. Sagara J.I., Miura K., Bannai S. Maintenance of neuronal glutathione by glial cells. J Neurochem. 61:1993;1672-1676.
32. Grisham M.B., Johnson G.G., Lancaster J.R. Quantification of nitrate and nitrite in extracellular fluids. Methods Enzymol. 268:1996;237-246.
33. Desagher S., Glowinski J., Premont J. Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci. 16:1996;2553-2568.
34. l-Glutamate: UV-method with glutaminase and glutamate dehydrogenase. In: Methods of Enzymatic Analysis, Vol. 8 (Ed. Bergmeyer HU), pp. 357-363. Verlag Chemie GmbH, Varlagsgesellschair, Weinheim, 1986.
35. Ye Z.C., Sontheimer H. Astrocytes protect neurons from neurotoxic injury by serum glutamate. Glia. 22:1998;237-248.
36. McGeer E.G., McGeer P.L. The role of the immune system in neurodegenerative disorders. Mov Disord. 12:1997;855-858.
37. Brown G.C., Bolaños J.P., Heales S.J., Clark J.B. Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration. Neurosci Lett. 193:1995;5275-5285.
38. Sorg O., Horn T.F., Yu N., Gruol D.L., Bloom F.E. Inhibition of astrocyte glutamate uptake by reactive oxygen species Role of antioxidant enzymes . Mol Med. 3:1997;431-440.
39. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J. 281:1992;627-630.
40. Pou S., Pou W.S., Bredt D.S., Snyder S.H., Rosen G.M. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem. 267:1992;24173-24176.
41. +) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem Biophys Res Commun. 170:1990;1049-1055.
42. Halliwell B. Mechanisms involved in the generation of free radicals. Pathol Biol. 44:1996;6-13.
43. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research therapy. Pharmacol Ther. 51:1991;155-194.
44. Drukarch B., Schepens E., Jongenelen C.A., Stoof J.C., Langeveld C.H. Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiency. Brian Res. 770:1997;123-130.
45. Dringen R., Hamprecht B. Involvement of glutathione peroxidase and catalase in the disposal of exogenous hydrogen peroxide by cultured astroglial cells. Brain Res. 759:1997;67-75.
46. Seaton T.A., Jenner P., Marsden C.D. Thioctic acid does not restore glutathione levels or protect against the potentiation of 6-hydroxydopamine toxicity induced by glutathione depletion in rats. J Neural Transm. 103:1996;315-329.
47. + toxicity in nigral dopaminergic neurones. Neuroreport. 7:1996;921-923.
48. Zuddas A., Oberto G., Vaglini F., Fascetti F., Fornai F., Corsini G.U. MK-801 prevents MPTP-induced parkinsonism in primates. J Neurochem. 59:1992;133-139.
49. Good P.F., Hsu A., Werner P., Perl D.P., Olanow C.W. Protein nitration in Parkinson's disease. J Neuropathol Exp Neurol. 57:1998;338-342.
50. McNaught KStP, Jenner P. Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures. J Neurochem. 73:1999;2469-2476.